Skip to main content

Oesophagus: Inflammatory Patterns

  • 997 Accesses

Abstract

Identifying inflammatory patterns in an oesophageal biopsy often gives important clues that lead to a specific aetiological diagnosis. Another important aspect of dealing with nonneoplastic oesophageal biopsies is to correctly identify conditions that have a potential to neoplastic progression as they need closer surveillance. It is vital to correlate the microscopic pattern in an endoscopic biopsy with clinical and endoscopic clues. This chapter details the patterns, clues and pitfalls in biopsy interpretation that leads to a clinically relevant conclusion highlighting key points. In addition to providing strategies for dealing with reactionary patterns, a series of short clinical stories that correlate important clinical, endoscopic and pathologic features are included. Illustration of key points and features are facilitated by a large number of high-quality photomicrographs.

Keywords

  • Inflammatory patterns
  • Oesophageal biopsy
  • Nonneoplastic oesophageal lesions
  • Neoplastic oesophageal lesions

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-319-79117-3_2
  • Chapter length: 44 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   119.00
Price excludes VAT (USA)
  • ISBN: 978-3-319-79117-3
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Hardcover Book
USD   159.99
Price excludes VAT (USA)
Fig. 2.1
Fig. 2.2
Fig. 2.3
Fig. 2.4
Fig. 2.5
Fig. 2.6
Fig. 2.7
Fig. 2.8
Fig. 2.9
Fig. 2.10
Fig. 2.11
Fig. 2.12
Fig. 2.13
Fig. 2.14
Fig. 2.15
Fig. 2.16
Fig. 2.17
Fig. 2.18
Fig. 2.19
Fig. 2.20
Fig. 2.21
Fig. 2.22
Fig. 2.23
Fig. 2.24

References

  1. Noffsinger AE. Update on esophagitis: controversial and underdiagnosed causes. Arch Pathol Lab Med. 2009;133(7):1087–95.

    PubMed  Google Scholar 

  2. Grin A, et al. Esophagitis: old histologic concepts and new thoughts. Arch Pathol Lab Med. 2015;139(6):723–9.

    CrossRef  PubMed  Google Scholar 

  3. Almashat SJ, Duan L, Goldsmith JD. Non-reflux esophagitis: a review of inflammatory diseases of the esophagus exclusive of reflux esophagitis. In Seminars in diagnostic pathology 2014, 31(2):89–99. WB Saunders, Philadelphia, PA.

    Google Scholar 

  4. Sutton FM, Graham DY, Goodgame RW. Infectious esophagitis. Gastrointest Endosc Clin N Am. 1994;4(4):713–29.

    CAS  CrossRef  PubMed  Google Scholar 

  5. Choi JH, Lee CG, Lim YJ, Kang HW, Lim CY, Choi JS. Prevalence and risk factors of esophageal candidiasis in healthy individuals: a single center experience in Korea. Yonsei Med J. 2013;54(1):160–5.

    CrossRef  PubMed  Google Scholar 

  6. Greenson JK. Infections of the esophagus. Am J Surg Pathol. 2002;7(1):19–26.

    Google Scholar 

  7. Greenson JK, Beschorner WE, Boitnott JK, Yardley JH. Prominent mononuclear cell infiltrate is characteristic of herpes esophagitis. Hum Pathol. 1991;22(6):541–9.

    CAS  CrossRef  PubMed  Google Scholar 

  8. Canalejo E, Durán FG, Cabello N, Martínez JG. Herpes esophagitis in healthy adults and adolescents: report of 3 cases and review of the literature. Medicine. 2010;89(4):204–10.

    CrossRef  PubMed  Google Scholar 

  9. Itoh T, Takahashi T, Kusaka K, Kawaura K, Nakagawa Y, Yamakawa JI, Kanda T. Herpes simplex esophagitis from 1307 autopsy cases. J Gastroenterol Hepatol. 2003;18(12):1407–11.

    CrossRef  PubMed  Google Scholar 

  10. Zimmermann D, Criblez DH, Dellon ES, Bussmann C, Pfeifer D, Froh M, Straumann A. Acute herpes simplex viral esophagitis occurring in 5 immunocompetent individuals with eosinophilic esophagitis. ACG Case Rep J. 2016;3(3):165.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  11. Wishingrad M. Sexually transmitted esophagitis: primary herpes simplex virus type 2 infection in a healthy man. Gastrointest Endosc. 1999;50(6):845–6.

    CAS  CrossRef  PubMed  Google Scholar 

  12. Kato S, Yamamoto R, Yoshimitsu S, et al. Herpes simplex esophagitis in the immunocompetent host. Dis Esophagus. 2005;18:340.

    CAS  CrossRef  PubMed  Google Scholar 

  13. Marinho AV, Bonfim VM, de Alencar LR, Pinto SA, de Araújo Filho JA. Herpetic esophagitis in immunocompetent medical student. Case Rep Infect Dis. 2014;2014:930459.

    PubMed  PubMed Central  Google Scholar 

  14. Kadayakkara DK, Candelaria A, Kwak YE, Loeser C. Herpes simplex virus-2 esophagitis in a young immunocompetent adult. Case Rep Gastroint Med. 2016;2016:7603484.

    Google Scholar 

  15. Cowdry EV. The problem of intranuclear inclusions in virus diseases. Arch Pathol. 1934;18:527–42.

    Google Scholar 

  16. Ranjan P, Gupta V, Goyal M, Dhawan S, Gupta P, Kumar M, Sachdeva M. Cytomegalovirus infection in gastrointestinal tract: a case series of three patients and review of literature. J Digest Endosc. 2015;6(3):133.

    CrossRef  Google Scholar 

  17. Wang H, Kuo C, Lin W, et al. The clinical characteristics and manifestations of cytomegalovirus esophagitis. Dis Esophagus. 2016;29:392.

    CrossRef  PubMed  Google Scholar 

  18. Schwartz DA, Wilcox CM. Atypical cytomegalovirus inclusions in gastrointestinal biopsy specimens from patients with the acquired immunodeficiency syndrome: diagnostic role of in situ nucleic acid hybridization. Hum Pathol. 1992;23(9):1019–26.

    CAS  CrossRef  PubMed  Google Scholar 

  19. Bonetti R. Luca, et al. Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. Scand J Gastroenterol. 2011;46(10):1228–35.

    CrossRef  Google Scholar 

  20. Greenson JK. Macrophage aggregates in cytomegalovirus esophagitis. Hum Pathol. 1997;28(3):375–8.

    CAS  CrossRef  PubMed  Google Scholar 

  21. Pape M, Mandraveli K, Sidiropoulos I, Koliouskas D, Alexiou-Daniel S, Frantzidou F. Unusual Epstein-Barr esophageal infection in an immunocompetent patient: a case report. J Med Case Reports. 2009;3(1):7314.

    CrossRef  PubMed Central  Google Scholar 

  22. Rudolph I, Goldstein F, DiMarino AJ. Crohn’s disease of the esophagus: three cases and a literature review. Canadian J Gastroenterol Hepatol. 2001;15(2):117–22.

    CAS  Google Scholar 

  23. Naranjo-Rodríguez A, Solórzano-Peck G, López-Rubio F, Calañas-Continente A, Gálvez-Calderón C, González-Galilea A, Hervás-Molina A. Isolated oesophageal involvement of Crohn’s disease. Eur J Gastroenterol Hepatol. 2003;15(10):1123–6.

    CrossRef  PubMed  Google Scholar 

  24. Geboes K, Janssens J, Rutgeerts P, Vantrappen G. Crohn’s disease of the esophagus. J Clin Gastroenterol. 1986;8:31.

    CAS  CrossRef  PubMed  Google Scholar 

  25. Decker GA, Loftus EV, Pasha TM, Tremaine WJ, Sandborn WJ. Crohn’s disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis. 2001;7(2):113–9.

    CAS  CrossRef  PubMed  Google Scholar 

  26. Mashako MN, Cezard JP, Navarro J, Mougenot JF, Sonsino E, Gargouri A, Maherzi A. Crohn’s disease lesions in the upper gastrointestinal tract: correlation between clinical, radiological, endoscopic, and histological features in adolescents and children. J Pediatr Gastroenterol Nutr. 1989;8(4):442–6.

    CAS  CrossRef  PubMed  Google Scholar 

  27. De Felice KM, Katzka DA, Raffals LE. Crohn’s disease of the esophagus: clinical features and treatment outcomes in the biologic era. Inflamm Bowel Dis. 2015;21(9):2106–13.

    CrossRef  PubMed  Google Scholar 

  28. Pantanowitz L, Gelrud A, Apstein M, Nasser I. Crohn’s disease of the esophagus. Ear Nose Throat J. 2004;83:420–2.

    PubMed  Google Scholar 

  29. Roy-Ghanta S, Larosa DF, Katzka DA. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2008;6(5):531–5.

    CrossRef  PubMed  Google Scholar 

  30. Kim HP, Vance RB, Shaheen NJ, Dellon ES. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(9):988–96.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  31. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, Burks AW, Chehade M, Collins MH, Dellon ES, Dohil R. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3–20.

    CrossRef  PubMed  Google Scholar 

  32. Yantiss RK. Eosinophils in the GI tract: how many is too many and what do they mean? Mod Pathol. 2015;28:S7–21.

    CrossRef  PubMed  Google Scholar 

  33. Lee S, de Boer WB, Naran A, Leslie C, Raftopoulous S, Ee H, Kumarasinghe MP. More than just counting eosinophils: proximal oesophageal involvement and subepithelial sclerosis are major diagnostic criteria for eosinophilic oesophagitis. J Clin Pathol. 2010;63(7):644–7.

    CrossRef  PubMed  Google Scholar 

  34. Dellon ES, Speck O, Woodward K, Covey S, Rusin S, Shaheen NJ, Woosley JT. Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy. Mod Pathol. 2015;28(3):383–90.

    CrossRef  PubMed  Google Scholar 

  35. Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108(5):679–92.

    CrossRef  PubMed  Google Scholar 

  36. Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. Dig Dis Sci. 1993;38(1):109–16.

    CAS  CrossRef  PubMed  Google Scholar 

  37. Davis BP, Rothenberg ME. Mechanisms of disease of eosinophilic esophagitis. Annu Rev Pathol. 2016;11:365–93.

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  38. García-Compeán D, González JA, García CA, Gutiérrez JP, Quintana OB, Rodríguez GG, Ruiz MA, de León Valdez D, Quintana JO, Garza HJ. Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: a prospective study. Dig Liver Dis. 2011;43(3):204–8.

    CrossRef  PubMed  Google Scholar 

  39. Kapel RC, Miller JK, Torres C, Aksoy S, Lash R, Katzka DA. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology. 2008;134(5):1316–21.

    CrossRef  PubMed  Google Scholar 

  40. Sherrill JD, Rothenberg ME. Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies. J Allergy Clin Immunol. 2011;128(1):23–32.

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  41. Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62(4):489–95.

    CrossRef  CAS  PubMed  Google Scholar 

  42. Lucendo AJ, Molina-Infante J, Arias Á, von Arnim U, Bredenoord AJ, Bussmann C, Amil Dias J, Bove M, González-Cervera J, Larsson H, Miehlke S. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J. 2017;5(3):335–58.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  43. Rubio CA, Sjödahl K, Lagergren J. Lymphocytic esophagitis. Am J Clin Pathol. 2006;125(3):432–7.

    CrossRef  PubMed  Google Scholar 

  44. Cohen S, Saxena A, Waljee A, Piraka C, Purdy J, Appelman H, McKenna B, Elmunzer BJ, Singal AG. Lymphocytic esophagitis: a diagnosis of increasing frequency. J Clin Gastroenterol. 2012;46(10):828.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  45. Conner JR, Sanchez CA, Reid BJ, Vaughan TL, Blount PL, Wang HH, Odze RD, Srivastava A. Lymphocytic esophagitis in Barrett’s esophagus: correlation with patient symptoms and risk factors. In: Laboratory investigation, vol. 94. New York, NY: Nature Publishing Group; 2014. p. 169A–70A.

    Google Scholar 

  46. Ebach DR, Vanderheyden AD, Ellison JM, Jensen CS. Lymphocytic esophagitis: a possible manifestation of pediatric upper gastrointestinal Crohn’s disease. Inflamm Bowel Dis. 2011;17(1):45–9.

    CrossRef  PubMed  Google Scholar 

  47. Sutton L, Heintz D, Patel A, Weinberg A. Lymphocytic esophagitis in children. Inflamm Bowel Dis. 2014;20:1324.

    CrossRef  PubMed  Google Scholar 

  48. Kissiedu J, Thota PN, Gohel T, Lopez R, Gordon IO. Post-ablation lymphocytic esophagitis in Barrett esophagus with high grade dysplasia or intramucosal carcinoma. Mod Pathol. 2016;29:599.

    CrossRef  PubMed  Google Scholar 

  49. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945–56.

    CrossRef  PubMed  Google Scholar 

  50. Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, Moresi JM, Greenson J, Janin A, Martin PJ, McDonald G. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology working group report. Biol Blood Marrow Transplant. 2006;12(1):31–47.

    CrossRef  PubMed  Google Scholar 

  51. Parfitt JR, Jayakumar S, Driman DK. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol. 2008;32(9):1367–72.

    CrossRef  PubMed  Google Scholar 

  52. Panarelli NC. Drug-induced injury in the gastrointestinal tract. In Seminars in diagnostic pathology 2014, 31(2):165–175. WB Saunders, Philadelphia, PA.

    Google Scholar 

  53. Chen Z, Scudiere JR, Montgomery E. Medication-induced upper gastrointestinal tract injury. J Clin Pathol. 2009;62(2):113–9.

    CAS  CrossRef  PubMed  Google Scholar 

  54. Misdraji J. Drug-induced pathology of the upper gastrointestinal tract. Diagn Histopathol. 2008;14(9):411–8.

    CrossRef  Google Scholar 

  55. Seminerio J, et al. Medication-associated lesions of the GI tract. Gastrointest Endosc. 2014;79(1):140–50.

    CrossRef  PubMed  Google Scholar 

  56. Boyce HW Jr. Drug-induced esophageal damage: diseases of medical progress. Gastrointest Endosc. 1998;47:547–50.

    CrossRef  PubMed  Google Scholar 

  57. Shih AR, et al. Drug-induced pathology of the upper gastrointestinal tract. Diagn Histopathol. 2017;23(2):84–95.

    CrossRef  Google Scholar 

  58. Daniels JA, et al. Gastrointestinal tract epithelial changes associated with taxanes: marker of drug toxicity versus effect. Am J Surg Pathol. 2008;32(3):473–7.

    CrossRef  PubMed  Google Scholar 

  59. Abraham SC, Cruz-Correa M, Lee LA, Yardley JH, Wu TT. Alendronate-associated esophageal injury: pathologic and endoscopic features. Mod Pathol. 1999;12(12):1152–7.

    CAS  PubMed  Google Scholar 

  60. Nagano Y, Matsui H, Shimokawa O, et al. Bisphosphonate-induced gastrointestinal mucosal injury is mediated by mitochondrial superoxide production and lipid peroxidation. J Clin Biochem Nutr. 2012;51:196–203.

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Abraham SC, Bhagavan BS, Lee LA, Rashid A, Wu TT. Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. Am J Surg Pathol. 2001;25(5):637–44.

    CAS  CrossRef  PubMed  Google Scholar 

  62. Xiao SY, Zhao L, Hart J, Semrad CE. Doxycycline-induced gastric and esophageal mucosal injuries with vascular degeneration. Am J Surg Pathol. 2013;37(7):1115–6.

    CrossRef  PubMed  Google Scholar 

  63. Brown IS, Bettington M. Doxycycline induced oesophagitis: five cases highlighting a distinctive pattern of injury. Pathology. 2017;49(1):90–2.

    CAS  CrossRef  PubMed  Google Scholar 

  64. Banisaeed N, Truding RM, Chang CH. Tetracycline-induced spongiotic esophagitis: a new endoscopic and histopathologic finding. Gastrointest Endosc. 2003;58(2):292–4.

    CrossRef  PubMed  Google Scholar 

  65. Swanson BJ, Limketkai BN, Liu TC, et al. Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury. Am J Surg Pathol. 2013;37:1686e93.

    CrossRef  Google Scholar 

  66. Purdy JK, Appelman HD, McKenna BJ. Sloughing esophagitis is associated with chronic debilitation and medications that injure the esophageal mucosa. Mod Pathol. 2012;25(5):767–75.

    CrossRef  PubMed  Google Scholar 

  67. Carmack SW, Vemulapalli R, Spechler SJ, Genta RM. Esophagitis dissecans superficialis (“sloughing esophagitis”): a clinicopathologic study of 12 cases. Am J Surg Pathol. 2009;33(12):1789–94.

    CrossRef  PubMed  Google Scholar 

  68. Ma C, Limketkai BN, Montgomery EA. Recently highlighted non-neoplastic pathologic entities of the upper GI tract and their clinical significance. Gastrointest Endosc. 2014;80(6):960–9.

    CrossRef  PubMed  Google Scholar 

  69. Patil R, Sunkara T, Ona MA, Gaduputi V, Reddy M. Fungal esophagitis presenting with esophagitis dissecans superficialis: cause or concurrence? A diagnostic conundrum. Gastroenterol Res. 2016;9(6):108.

    CrossRef  Google Scholar 

  70. Hart PA, Romano RC, Moreira RK, Ravi K, Sweetser S. Esophagitis dissecans superficialis: clinical, endoscopic, and histologic features. Dig Dis Sci. 2015;60(7):2049–57.

    CrossRef  PubMed  Google Scholar 

  71. De S, Williams G. Esophagitis dissecans superficialis: a case report and literature review. Can J Gastroenterol. 2013;27(10):563.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  72. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw M, Talley NJ. An evidence-based appraisal of reflux disease management—the Genval Workshop Report. Gut. 1998;44(suppl 2):S1–6.

    Google Scholar 

  73. Mattox HE, Richter JE. Prolonged ambulatory esophageal pH monitoring in the evaluation of gastroesophageal reflux disease. Am J Med. 1990;89(3):345–56.

    CrossRef  PubMed  Google Scholar 

  74. Vantrappen G, Janssens J. Gastro-oesophageal reflux disease, an important cause of angina-like chest pain. Scand J Gastroenterol Suppl. 1988;168:73–9.

    Google Scholar 

  75. Sontag SJ. Gastroesophageal reflux and asthma. Am J Med. 1997;103:84S–90S.

    CAS  CrossRef  PubMed  Google Scholar 

  76. Fiocca R, Mastracci L, Riddell R, Takubo K, Vieth M, Yerian L, Sharma P, Fernström P, Ruth M. Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum Pathol. 2010;41(2):223–31.

    CrossRef  PubMed  Google Scholar 

  77. Krugmann J, Neumann H, Vieth M, Armstrong D. What is the role of endoscopy and oesophageal biopsies in the management of GERD? Best Pract Res Clin Gastroenterol. 2013;27(3):373–85.

    CrossRef  PubMed  Google Scholar 

  78. Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83(4):818–23.

    CAS  PubMed  Google Scholar 

  79. Srivastava A, Appelman H, Goldsmith JD, Davison JM, Hart J, Krasinskas AM. The Use of Ancillary Stains in the Diagnosis of Barrett Esophagus and Barrett Esophagus–associated Dysplasia Recommendations From the Rodger C. Haggitt Gastrointestinal Pathology Society. Am J Surg Pathol. 2017;41:e8–e21.

    CrossRef  PubMed  Google Scholar 

  80. Younes M, Ertan A, Ergun G, et al. Goblet cell mimickers in esophageal biopsies are not associated with an increased risk for dysplasia. Arch Pathol Lab Med. 2007;131:571–5.

    PubMed  Google Scholar 

  81. Smith J, et al. Intestinal metaplasia is present in most if not all patients who have undergone endoscopic mucosal resection for esophageal adenocarcinoma. Am J Surg Pathol. 2016;40:537–43.

    CrossRef  PubMed  Google Scholar 

  82. Allanson BM, Bonavita J, Mirzai B, Khor TS, Raftopoulos SC, de Boer WB, Brown IS, Kumarasinghe MP. Early Barrett esophagus-related neoplasia in segments 1 cm or longer is always associated with intestinal metaplasia. Mod Pathol. 2017;30:1170. https://doi.org/10.1038/modpathol.2017.36.

    CAS  CrossRef  PubMed  Google Scholar 

  83. Paull A, Trier J, Dalton D, et al. The histologic spectrum of Barrett’s esophagus. N Engl J Med. 1976;295:476–80.

    CAS  CrossRef  PubMed  Google Scholar 

  84. Chandrasoma PT, Der R, Dalton P, et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol. 2001;25:1188–93.

    CAS  CrossRef  PubMed  Google Scholar 

  85. Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett’s Esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103:1049–57.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  86. Hvid-Jensen F, Pedersen L, Drewes AM, et al. Incidence of Adenocarcinoma among Patients with Barrett’s Esophagus. N Engl J Med. 2011;365:1375.

    CAS  CrossRef  PubMed  Google Scholar 

  87. Bansal A, McGregor DH, Anand O, et al. Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett’s esophagus. Dis Esophagus. 2014;27(8):751–6.

    CAS  CrossRef  PubMed  Google Scholar 

  88. Spechler SJ, Sharma P, Souza RF, et al. American gastroenterological association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–91.

    CrossRef  PubMed  Google Scholar 

  89. Shaheen NJ, Falk GW, Iyer PG, et al. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2015;108:1238–49.

    Google Scholar 

  90. Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O’donovan M. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42.

    CrossRef  PubMed  Google Scholar 

  91. Whiteman DC, Appleyard M, Bahin FF, Bobryshev YV, Bourke MJ, Brown I, Chung A, Clouston A, Dickins E, Emery J, Eslick GD. Australian clinical practice guidelines for the diagnosis and management of Barrett’s esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol. 2015;30(5):804–20.

    CrossRef  PubMed  Google Scholar 

  92. Oberg S, Johansson J, Wenner J, et al. Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery. Ann Surg. 2001;234:619–26.

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  93. Salaria SN, et al. Lichenoid esophagitis: clinicopathologic overlap with established esophageal lichen planus. Am J Surg Pathol. 2013;37(12):1889–94.

    CrossRef  PubMed  Google Scholar 

  94. Ma C, Limketkai BN, Montgomery EA. Recently highlighted non-neoplastic pathologic entities of the upper GI tract and their clinical significance. Gastrointest Endosc. 2014;80(6):960–9.

    CrossRef  PubMed  Google Scholar 

  95. Katzka DA, Smyrk TC, Bruce AJ, et al. Variations in presentations of esophageal involvement in lichen planus. Clin Gastroenterol Hepatol. 2010;8:777–82.

    CrossRef  PubMed  Google Scholar 

  96. Chandan VS, Murray JA, Abraham SC. Esophageal lichen planus. Arch Pathol Lab Med. 2008;132(6):1026–9.

    PubMed  Google Scholar 

  97. Cottreau J, Gruchy S, Kamionek M, Lauwers GY, Arnason T. Prevalence of oesophageal epidermoid metaplasia in 1048 consecutive patients and 58 patients with squamous neoplasms. Histopathology. 2016;68:988.

    CrossRef  PubMed  Google Scholar 

  98. Singhi AD, Arnold CA, Crowder CD, Lam-Himlin DM, Voltaggio L, Montgomery EA. Esophageal leukoplakia or epidermoid metaplasia: a clinicopathological study of 18 patients. Mod Pathol. 2014;27(1):38–43.

    CrossRef  PubMed  Google Scholar 

  99. Dhungel BM, De Petris G. Bizarre stromal cells in the esophagus: report of 2 cases and literature review. Int J Surg Pathol. 2013;21:368–72.

    CrossRef  PubMed  Google Scholar 

  100. Simonetta Piana MD. Riccardo Valli, Roberto Igino Sacchero, Bizarre Stromal Cells in the Esophagus. A New Case. Int J Surg Pathol. 2014;22(4):383–4.

    CrossRef  PubMed  Google Scholar 

  101. Gill P, Piris J, Warren BF. Bizarre stromal cells in the esophagus. Histopathology. 2003;42:88–90.

    CAS  CrossRef  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Verify currency and authenticity via CrossMark

Cite this chapter

Ahadi, M.S., Gill, A.J., Turchini, J.R., Raftopoulos, S.C., Kumarasinghe, M.P. (2019). Oesophagus: Inflammatory Patterns. In: Kumarasinghe, M., Brown, I. (eds) Endoscopic Biopsy Interpretation. Springer, Cham. https://doi.org/10.1007/978-3-319-79117-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-79117-3_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-79116-6

  • Online ISBN: 978-3-319-79117-3

  • eBook Packages: MedicineMedicine (R0)